KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Prepaid Assets: 2009-2025

Historic Prepaid Assets for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Sep 2025 value amounting to $315.4 million.

  • Jazz Pharmaceuticals' Prepaid Assets fell 10.95% to $315.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $315.4 million, marking a year-over-year decrease of 10.95%. This contributed to the annual value of $261.5 million for FY2024, which is 18.47% down from last year.
  • Jazz Pharmaceuticals' Prepaid Assets amounted to $315.4 million in Q3 2025, which was up 6.01% from $297.6 million recorded in Q2 2025.
  • Jazz Pharmaceuticals' 5-year Prepaid Assets high stood at $354.2 million for Q3 2024, and its period low was $147.7 million during Q1 2021.
  • Over the past 3 years, Jazz Pharmaceuticals' median Prepaid Assets value was $310.4 million (recorded in 2023), while the average stood at $298.0 million.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Prepaid Assets soared by 77.63% in 2021, and later decreased by 18.47% in 2024.
  • Quarterly analysis of 5 years shows Jazz Pharmaceuticals' Prepaid Assets stood at $252.4 million in 2021, then rose by 5.86% to $267.2 million in 2022, then grew by 20.07% to $320.8 million in 2023, then dropped by 18.47% to $261.5 million in 2024, then declined by 10.95% to $315.4 million in 2025.
  • Its last three reported values are $315.4 million in Q3 2025, $297.6 million for Q2 2025, and $259.8 million during Q1 2025.